Call Us
Tap on a number to call
Enquire
Log In
Menu
Contact Us
Call Us
Tap on a number to call
Enquire

Dr Vyasa Immadisetty

Consultant Psychiatrist

About

Dr Vyasa Immadisetty is a highly experienced consultant psychiatrist with over 22 years of psychiatric practice and more than 13 years of experience as a consultant psychiatrist within the NHS. He is a fellow of the Royal College of Psychiatrists (FRCPsych), an approved clinician under the Mental Health Act, and is listed on the general medical council specialist register with dual accreditation in general adult psychiatry and substance misuse psychiatry.

Dr Immadisetty currently serves as clinical director for adult mental health services and consultant psychiatrist for Essex Partnership University NHS Foundation Trust (EPUT). He provides strategic clinical leadership across community and inpatient mental health services and leads the clinical aspects of county-wide addiction services, delivering care to individuals with complex mental health and substance misuse needs.

Alongside his NHS leadership role, Dr Immadisetty works as a visiting consultant psychiatrist at Priory Hospital Chelmsford and serves as a health examiner and medical supervisor for the general medical council, supporting doctors experiencing mental health difficulties and health-related fitness-to-practise concerns.

Throughout his career, he has worked across community, outpatient, liaison, inpatient, rehabilitation and specialist addiction services, gaining extensive experience in the management of depressive illnesses, affective disorders, neurotic conditions, psychotic disorders and complex dual-diagnosis presentations.

His practice is characterised by a compassionate, collaborative and evidence-based approach that integrates biological, psychological and social perspectives to deliver personalised treatment for each individual.

Dr Immadisetty has particular expertise in managing highly complex patients where depression, anxiety, trauma, personality difficulties and addiction co-exist. His clinical approach emphasises comprehensive assessment, shared decision-making and recovery-focused care.

Leadership and management

Dr Immadisetty has held a number of senior clinical leadership positions throughout his career.
As clinical director for adult mental health services in North Essex, he provides medical leadership across multiple community and inpatient services. His responsibilities include medical workforce leadership, clinical governance, quality improvement, service transformation, policy development and strategic planning.

He previously served as clinical lead for addiction psychiatry in Essex and clinical lead for the Suffolk Recovery Network, where he successfully delivered service redesign programmes, introduced innovative treatment pathways and led significant improvements in quality, safety and patient outcomes.

He currently serves as the eastern division representative for addiction psychiatry within the Royal College of Psychiatrists, contributing to workforce planning, service development and professional standards across the region.

Position at Priory

Dr Immadisetty has been a visiting consultant psychiatrist at Priory Hospital Chelmsford since 2019 and has been re-registered more recently. 

He provides specialist outpatient psychiatric assessments and treatment for adults presenting with a wide range of mental health conditions and addictions. His work combines evidence-based pharmacological treatments with psychologically informed care tailored to the individual's needs and circumstances.

Training

Dr Immadisetty graduated in medicine from India, before moving to the United Kingdom to undertake specialist psychiatric training.

He completed comprehensive postgraduate training within the Severn Deanery, gaining experience across general adult psychiatry, addiction psychiatry, liaison psychiatry, forensic psychiatry, rehabilitation psychiatry, neuropsychiatry and child and adolescent psychiatry.

He obtained membership of the Royal College of Psychiatrists (MRCPsych) in 2007 and completed higher specialist training leading to the award of certificate of completion of training (CCT) in general adult psychiatry and substance misuse psychiatry in 2013.

He has held section 12 approval since 2007 and is an approved clinician under the Mental Health Act. In recognition of his contribution to psychiatry, leadership and service development, he was elected a fellow of the Royal College of Psychiatrists (FRCPsych).

He is currently completing an executive master's in medical leadership at Bayes Business School, City St George's University of London.

Research interests

Principal Investigator: FORWARDS-2 Study Facilitating Opiate Recovery: Withdrawal and Abstinence through Detoxification Support. Multi-centre NIHR-funded clinical study investigating the role of baclofen in supporting detoxification from methadone and improving treatment outcomes in opioid dependence.

Multi-Centre Research Collaboration
Taste Threshold Changes in Depression: A Possible Biomarker for Antidepressant Response
Study examining alterations in taste perception in depressive disorders before and after antidepressant treatment, exploring potential biological markers of treatment response.

Systematic Review
Clozapine-Induced Parotid Swelling and Treatment Strategies
Comprehensive review of mechanisms and management approaches for clozapine-induced parotid gland swelling.

Feasibility Study
Recidivism Outcomes in Medium Secure Units
Follow-up study examining characteristics and outcomes of patients discharged from medium secure forensic services.

International Conference Presentations and Posters

Royal College of Psychiatrists International Congress, Edinburgh (2024)
One Stop Addiction, Obstetrics and Perinatal Mental Health Pathway in North East Essex
Global Addiction Conference, Lisbon (2011)

Model of Communication in Acute Benzodiazepine Withdrawal
Annual Conference of the Indian Psychiatric Society (2012)

Review of Long-Term Use of Benzodiazepines in the Treatment of Anxiety Disorders
Annual Conference of the Indian Psychiatric Society (2012)

Taste Threshold Changes in Depression: A Possible Biomarker?
Management Training: An Add-On Necessity for Postgraduate Trainees in the UK

National Presentations

Royal College of Psychiatrists Faculty of Addictions Conference (2023)
A Case Study of Hyperprolactinaemia Induced by Buprenorphine

Royal College of Psychiatrists Faculty of Addictions Conference (2012)
A New Patient Preferred Model of Communication in Benzodiazepine Withdrawal
Awarded Second Prize

Regional Presentations

Eastern Division Spring Conference (2021)
Valproate Pregnancy Prevention Programme Quality Improvement Project
Awarded Second Prize

East of England Division Meeting (2018)
A New Pragmatic Model of Alcohol Detoxification and Rehabilitation in Community Settings

Clinical publications

  • Immadisetty V.
    Body Mapping: A Novel Tool for Psychiatrists.
    AP Journal of Psychological Medicine. 2012;13(2):115–118.
  • Immadisetty V, Agarwal P.
    A Successful Treatment Strategy for Clozapine-Induced Parotid Swelling: A Clinical Case and Systematic Review.
    Therapeutic Advances in Psychopharmacology. 2012;2(6):235–239.
  • Immadisetty V, Cant T, Thyarappa P, Lingford-Hughes A, Vernon J.
    Biomarkers for Detecting Thiamine Deficiency – Improving Confidence and Taking a Comprehensive History are also Important.
    Alcohol and Alcoholism. 2009;44(6):634.

Languages

  • English
  • Telugu
  • Hindi

Qualifications

  • Executive Master of Medical Leadership (EMML) – in progress
  • Fellow of the Royal College of Psychiatrists (FRCPsych)
  • Certificate of Completion of Training (CCT) – General & Substance Misuse Psychiatry
  • Member of the Royal College of Psychiatrists (MRCPsych)
  • Approved Clinician
  • Section 12 Approved Doctor
  • MBBS